Table 1.
Mantle cell lymphoma with endobronchial involvement
|
Ref.
|
Age
|
Gender
|
Time between MCL first diagnosis and endobronchial involvement
|
Smoking history
|
Presenting symptoms
|
CyclinD1
|
| Figgis et al[10] | 53 | Female | More than three years (second relapse) | N/A | Cough, dyspnoea, wheeze | N/A |
| Miyoshi et al[11] | 70 | Female | Five years (fifth relapse) | N/A | Stridor, respiratory failure | Positive |
| Imai et al[12] | 86 | Male | Two years (first relapse) | N/A | Dyspnoea | N/A |
| Katono et al[2] | 87 | Male | 0 (diagnosed by endobronchial biopsy) | Never-smoker | Dyspnoea on exertion | Positive |
| Tong et al[1] | 65 | Male | 0 (diagnosed by endobronchial biopsy) | Current smoker with 40 pack-years | Productive cough, dyspnoea | Positive |
| Current case | 56 | Male | 0 (diagnosed by endobronchial biopsy) | Current smoker with 30 pack-years | Cough | Positive |
N/A: Not applicable; MCL: Mantle cell lymphoma.